Axogen CEO Michael Dale sells 25,000 company shares at $30

Axogen, Inc. Chief Executive Officer Michael Dale reported selling 25,000 shares of the company’s common stock on 12/10/2025 at $30 per share.

Rhea-AI Filing Summary

Axogen, Inc. Chief Executive Officer Michael Dale reported selling 25,000 shares of the company’s common stock on 12/10/2025 at $30 per share. After this sale, he directly beneficially owns 63,537 shares of Axogen common stock.

Insider Trade Summary

Net Seller: 25,000 shares

Net Sell 1 txn

Insider DALE MICHAEL D

Role Chief Executive Officer

Sold 25,000 shs ($750K)

Type	Security	Shares	Price	Value
Sale	Common Stock	25,000	$30.00	$750K

Holdings After Transaction: Common Stock — 63,537 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Axogen (AXGN) report for December 2025?

Axogen reported that its Chief Executive Officer Michael Dale sold 25,000 shares of Axogen common stock on 12/10/2025 at $30 per share.

Who is the reporting person in this Axogen (AXGN) insider transaction?

The reporting person is Michael Dale, who serves as the Chief Executive Officer of Axogen, Inc.

How many Axogen (AXGN) shares does CEO Michael Dale own after the sale?

Following the reported transaction, CEO Michael Dale directly beneficially owns 63,537 shares of Axogen common stock.

At what price were the Axogen (AXGN) shares sold in this transaction?

The 25,000 shares of Axogen common stock were sold at a price of $30 per share.

What type of security did the Axogen (AXGN) CEO sell?

The transaction involved sales of Axogen common stock by the company’s Chief Executive Officer.

Is this Axogen (AXGN) insider report filed by a single reporting person?

Yes. The form indicates it is filed by one reporting person, covering CEO Michael Dale’s holdings.

What is Michael Dale’s relationship to Axogen (AXGN)?

Michael Dale is identified as an officer of Axogen, Inc., with the title of Chief Executive Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DALE MICHAEL D

(Last) (First) (Middle)

13631 PROGRESS BLVD.,

SUITE 400

(Street)

ALACHUA FL 32615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Axogen, Inc. [ AXGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		S		25,000	D	$30	63,537	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark Began, as attorney-in-fact for Michael Dale	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.